GlassScriptPhysician profile
Barry M Kay
NPI 1285619908
$10,780.67
in general payments reported to CMS, 2019-2025
21 companies · $1,646 in 2025
The $1,646 reported for 2025 was more than what 96% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,936 · 2020: $756 · 2021: $880 · 2022: $1,457 · 2023: $2,823 · 2024: $1,284 · 2025: $1,646.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,681 · Travel and Lodging: $1,071.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,681.27 |
| Travel and Lodging | $1,070.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $4,082.15 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $1,436.42 | 2022-2025 | Infuse, Infuse Multifocal, Miebo |
| Alcon Vision LLC | $1,401.45 | 2019-2025 | Total30, Dailies Total1, Precision 1 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $720.10 | 2019-2021 | |
| Coopervision INC. | $628.96 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens, Cvi Contact Lens |
| Glaukos Corporation | $470.31 | 2019-2025 | Kxl System (Not Refurbished) |
| Maculogix, INC. | $340.51 | 2019-2020 | |
| Abbvie INC. | $321.07 | 2022-2025 | |
| Horizon Therapeutics Plc | $240.25 | 2021-2022 | |
| New World Medical,INC. | $224.23 | 2023-2025 | Via360, Kahook Dual Blade, Ahmed Glaucoma Valve |
| Genentech USA, INC. | $136.56 | 2019 | |
| Apellis Pharmaceuticals, INC. | $124.99 | 2023 | |
| Optos, INC. | $116.35 | 2020-2022 | |
| Shire North American Group INC | $104.32 | 2019 | |
| Sun Pharmaceutical Industries INC. | $92.97 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $92.01 | 2019 | |
| Rxsight INC | $86.38 | 2024 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Injector Handpiece |
| Johnson & Johnson Surgical Vision, INC. | $74.45 | 2019 | |
| Alcon Research LLC | $49.53 | 2019 | |
| Visioneering Technologies, INC. | $21.17 | 2020 | |
| Allergan, INC. | $16.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Kay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.